Human blood marker points to a compound that slows ALS in mice

Amyotrophic lateral sclerosis (ALS) is a severe neurological disease that destroys nerve cells responsible for muscle movement. The disease typically begins with limb or bulbar weakness and progresses to respiratory failure. Current treatments only modestly slow progression, underscoring the urgent need for more effective therapies.